Shanghai Lung Cancer Center, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China.
Cell Adh Migr. 2020 Dec;14(1):82-95. doi: 10.1080/19336918.2020.1766308.
: The analysis of the online databases revealed that CCND1 expression is correlated with poor prognosis in LSCC. We aimed to explore the function of CCND1 in tumor progression in LSCC.: The expression of mRNA was measured using qRT-PCR. Protein expression was assessed by Western blot. Cell migration and invasion were assessed by transwell assay.: CCND1 was co-overexpressed with FGFR1 in lung cancer patients. Overexpression of CCND1 promoted LSCC cell proliferation and metastasis. FGFR1 promoted the processes of EMT through AKT/MAPK signaling by targeting CCND1 in FGFR1-amplification cell lines.: IIn conclusion, our study demonstrated the regulatory mechanism between CCND1 and FGFR1 in FGFR1 amplified LSCC. Co-targeting CCND1 and FGFR1 could provide greater clinical benefits.
: 在线数据库分析显示,CCND1 的表达与 LSCC 的预后不良相关。我们旨在探讨 CCND1 在 LSCC 肿瘤进展中的作用。: 使用 qRT-PCR 测量 mRNA 的表达。通过 Western blot 评估蛋白表达。通过 Transwell 测定评估细胞迁移和侵袭。: CCND1 在肺癌患者中与 FGFR1 共过表达。过表达 CCND1 促进 LSCC 细胞的增殖和转移。FGFR1 通过在 FGFR1 扩增细胞系中靶向 CCND1 来通过 AKT/MAPK 信号通路促进 EMT 过程。: 总之,我们的研究表明了 FGFR1 扩增 LSCC 中 CCND1 和 FGFR1 之间的调节机制。共同靶向 CCND1 和 FGFR1 可能会带来更大的临床获益。